Brief: NW Bio announces $40 million financing
02/04/2015 16:55
April 2 (Reuters) - Northwest Biotherapeutics Inc NWBO.O : * NW Bio announces $40 million financing * Entered into agreement with Woodford Investment Management LLP as agent for CF Woodford equity income fund, other clients * Woodford will purchase $40 million of the company's common stock at $7.40 per share, for a total of 5.4 million shares * Source text for Eikon ID:nPn9d48yW * Further company coverage NWBO.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB